D-0556-2024 Class III Ongoing
FDA drug recall D-0556-2024 was initiated by Eugia US LLC on May 22, 2024 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer. The recall status is ongoing. Affected quantity: 15,500 single dose vials.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 26, 2024
- Initiation Date
- May 22, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 15,500 single dose vials
Product description
Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10
Reason for recall
Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
Distribution pattern
USA nationwide.
Code information
Lot #: 3EF22003, Exp 6/30/2025
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0556-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026